Caballero, Editha R.

HRN: 22-86-03  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/10/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
04/10/2023
04/20/2023
IV
1.5gm
QID
Infected Wound
Waiting Final Action 
04/10/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
04/10/2023
04/20/2023
IV
600mg
QID
Infected Wound
Waiting Final Action 
04/20/2023
CLINDAMYCIN 300MG (CAP)
04/20/2023
04/22/2023
PO
300mg
Q8
DM Foot
Waiting Final Action 
04/21/2023
CEFTRIAXONE 1G (VIAL)
04/21/2023
04/27/2023
IV
2grams
OD
Infected Wound
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: